1-2 of 2
Gregor E.G. Verhoef
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

HOVON 50/GMMG-HD3-Trial: Phase III Study on the Effect of Thalidomide Combined with High Dose Melphalan in Myeloma Patients up to 65 Years.

Hartmut Goldschmidt, Pieter Sonneveld, Iris Breitkreuz, Bronno van der Holt, Axel Benner, Renee M.Y. Barge, Hans Salwender, Gerard M.J. Bos, Axel Glasmacher, Reinier Raymakers, Christof Scheid, Peter C. Huijgens, Ralph Naumann, Marinus H.J. van Oers, Annette Hänel, Edo Vellenga, Hans Martin, Pierre W. Wijermans, Anthony D. Ho, Petra H.M. Westveer, Gregor E.G. Verhoef, Uta Mazitschek, Henk M. Lokhorst
Journal: Blood
Blood (2005) 106 (11): 424.
https://doi.org/10.1182/blood.V106.11.424.424
Published: 2005
Journal Articles

High Rates of Molecular Response and Low Incidence of Mutations in Patients Treated with Newly Diagnosed Chronic Myeloid Leukemia (CML) Treated with a Dose-Escalated Combination of Imatinib and Cytarabin.

Jan J. Cornelissen, MD, PhD, Peter Valk, PhD, Gregor E.G. Verhoef, MD, PhD, Wim M. Smit, MD, PhD, Marinus van Marwijk-Kooij, MD, PhD, Shulamit Wittebol, MD, Marinus H.J. van Oers, MD, PhD, Hanneke C. Kluin-Nelemans, MD, PhD, Bob Lowenberg, MD, PhD, Roelof Willemze, MD, PhD, Antonius V.M.B. Schattenberg, MD, PhD, Gert Ossenkoppele, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 19.
https://doi.org/10.1182/blood.V104.11.19.19
Published: 2004